Brian Druker Part 1: Imatinib (Gleevec): A Targeted Cancer Therapy


(33:54 minutes)
View in larger 640x480 format
Part 2: Imatinib Resistance and Other Diseases Targeted by Imatinib
(25:12) minutes)




Part 3: Extending the Imatinib Paradigm
(22:09) minutes)



Trouble Viewing?
Watch on YouTube or iTunes U


Download as (Right click -- "Save as"):

Overview
Speaker Bio
Related Articles